ResearchDISCOVERCompleted

IISc study finds isoniazid+vancomycin can reverse drug-resistant TB in lab and mice

Bengaluru, Karnataka17 Nov 2026

Researchers at the Indian Institute of Science (IISc), Bengaluru reported a treatment strategy combining isoniazid with vancomycin that reversed isoniazid resistance in clinical isolates of Mycobacterium tuberculosis and reduced bacterial burden in a mouse model. The findings were published in the journal Microbiology Spectrum and involved testing against patient-derived sputum isolates in collaboration with the National Tuberculosis Institute, Bengaluru.

Why it matters

If validated further, the combination could help recover the usefulness of isoniazid against drug-resistant TB, potentially expanding treatment options without relying only on new drugs.

Indian Institute of Science (IISc)National Tuberculosis Institute, Bengaluru